Comments
Novartis's drug reduces heart failure deaths: study
24.09.2012. | ZURICH (Reuters) - Novartis's investigational medicine RLX030 reduced the number of deaths in patients with acute heart failure, the drugmaker said on Monday based on the results of a late-stage trial....
